TD Cowen Reiterates Buy on TransMedics Group, Maintains $120 Price Target

Benzinga · 1d ago
TD Cowen analyst Joshua Jennings reiterates TransMedics Group (NASDAQ:TMDX) with a Buy and maintains $120 price target.